165 related articles for article (PubMed ID: 24946846)
1. High intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusion.
Tuuminen R; Loukovaara S
Eye (Lond); 2014 Sep; 28(9):1095-9. PubMed ID: 24946846
[TBL] [Abstract][Full Text] [Related]
2. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
[TBL] [Abstract][Full Text] [Related]
3. Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Hori S
Eur J Ophthalmol; 2008; 18(6):1017-9. PubMed ID: 18988180
[TBL] [Abstract][Full Text] [Related]
4. Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.
Loukovaara S; Lehti K; Robciuc A; Pessi T; Holopainen JM; Koli K; Immonen I; Keski-Oja J
Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):881-8. PubMed ID: 24218041
[TBL] [Abstract][Full Text] [Related]
5. Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion.
Ki-I Y; Arimura N; Noda Y; Yamakiri K; Doi N; Hashiguchi T; Maruyama I; Shimura M; Sakamoto T
Curr Eye Res; 2007 Dec; 32(12):1065-72. PubMed ID: 18085471
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
[TBL] [Abstract][Full Text] [Related]
7. Statins in rhegmatogenous retinal detachment are associated with low intravitreal angiopoietin-2, VEGF and MMP-2 levels, and improved visual acuity gain in vitrectomized patients.
Tuuminen R; Haukka J; Loukovaara S
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1685-93. PubMed ID: 25432094
[TBL] [Abstract][Full Text] [Related]
8. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
9. Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema.
Stahl A; Buchwald A; Martin G; Junker B; Chen J; Hansen LL; Agostini HT; Smith LE; Feltgen N
Retina; 2010 Oct; 30(9):1524-9. PubMed ID: 20664492
[TBL] [Abstract][Full Text] [Related]
10. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
Guo S; Ren J; Li Z; Fan X; Qin L; Li J
Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion.
Zeng Y; Cao D; Yu H; Zhuang X; Yang D; Hu Y; He M; Zhang L
Mol Vis; 2019; 25():756-765. PubMed ID: 31814701
[TBL] [Abstract][Full Text] [Related]
12. Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy.
Luo Y; Wan J; Luo C; Liu H; Zhou Y; Xu H; Chen Z
Br J Ophthalmol; 2021 Jul; 105(7):1029-1034. PubMed ID: 31843793
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema.
Noma H; Funatsu H; Mimura T; Harino S; Eguchi S; Hori S
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1559-65. PubMed ID: 20714746
[TBL] [Abstract][Full Text] [Related]
14. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Hori S
Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846
[TBL] [Abstract][Full Text] [Related]
15. [Intravitreal fibrinolysis and retinal vein occlusion].
Bertelmann T; Stief T; Sekundo W; Witteborn M; Strodthoff S; Mennel S; Nguyen N; Koss M
Ophthalmologe; 2015 Feb; 112(2):155-61. PubMed ID: 25305042
[TBL] [Abstract][Full Text] [Related]
16. Association between macular microcirculation and soluble intercellular adhesion molecule-1 in patients with macular edema and retinal vein occlusion.
Noma H; Funatsu H; Sakata K; Mimura T; Hori S
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1515-8. PubMed ID: 20309574
[TBL] [Abstract][Full Text] [Related]
17. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid-binding protein 4 is an independent factor in the pathogenesis of retinal vein occlusion.
Hikage F; Furuhashi M; Ida Y; Ohguro H; Watanabe M; Suzuki S; Itoh K
PLoS One; 2021; 16(1):e0245763. PubMed ID: 33503066
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
Zhang H; Xia Y
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
[TBL] [Abstract][Full Text] [Related]
20. Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion.
Ehlken C; Rennel ES; Michels D; Grundel B; Pielen A; Junker B; Stahl A; Hansen LL; Feltgen N; Agostini HT; Martin G
Am J Ophthalmol; 2011 Aug; 152(2):298-303.e1. PubMed ID: 21621189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
